Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Achilles Therapeutics plc - American Depositary Shares (NQ: ACHL )

1.405 +0.015 (+1.08%)
Streaming Delayed Price Updated: 3:56 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,224,740
Open 1.380
Bid (Size) 1.400 (183)
Ask (Size) 1.410 (184)
Prev. Close 1.390
Today's Range 1.380 - 1.410
52wk Range 0.6300 - 1.410
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
These stocks have an unusual volume in today's session
Unusual volume stocks in Tuesday's session 
Via Chartmill
On Thursday, there are stocks with unusual volume. Let's take a look.
Let's explore the current happenings on the US markets on Thursday. Below, you'll find the stocks exhibiting unusual volume in today's session. 
Via Chartmill

Performance

YTD
+23.23%
+23.23%
1 Month
+1.08%
+1.08%
3 Month
+37.75%
+37.75%
6 Month
+100.69%
+100.69%
1 Year
+14.23%
+14.23%

More News

Read More
These stocks have an unusual volume in today's session
Via Chartmill
Discover the top movers in Tuesday's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Achilles Therapeutics Announces $12M AstraZeneca Deal, Plans Job Cuts
Via Benzinga
Achilles Therapeutics Shares Are Trading Higher: What You Need To Know
Via Benzinga
ACHL Stock Earnings: Achilles Therapeutics Meets EPS for Q2 2024
Via InvestorPlace
Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines
From Achilles Therapeutics PLC
Via GlobeNewswire
ACHL Stock Earnings: Achilles Therapeutics Beats EPS for Q1 2024
Via InvestorPlace
Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
From Achilles Therapeutics PLC
Via GlobeNewswire
Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Nasdaq Surges 1%; ConAgra Brands Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
ACHL Stock Earnings: Achilles Therapeutics Misses EPS for Q4 2023
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights
From Achilles Therapeutics PLC
Via GlobeNewswire
Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning
From Achilles Therapeutics PLC
Via GlobeNewswire
Achilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference
From Achilles Therapeutics PLC
Via GlobeNewswire
Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction
From Achilles Therapeutics PLC
Via GlobeNewswire
Achilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights
From Achilles Therapeutics PLC
Via GlobeNewswire
10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis
Via ACCESSWIRE
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation
Via Investor Brand Network
Exposures Product Safety
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.